The CoreValve bioprosthesis was used in 724 of 863 patients (84%); the Evolut R bioprosthesis was used in 139 (16%) (Fig. S1 in the Supplementary Appendix).

The MATTISSE bioprosthesis, developed by the French MedTech company Lattice Medical, offers a third option.“This new technique combines reconstruction using the patient’s own tissue with a ...

Popma, JJ, Adams, DH, Reardon, MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--NaviGate Cardiac Structures Inc. (“NCSI”) announced today that on 2 Feb. 2018, its catheter-guided GATE™ valved-stent bioprosthesis beame the first ...

SAN FRANCISCO, CALIF.—A new self-expanding aortic bioprosthesis was linked to high procedural success at 30 days, according to a presentation at TCT 2011. Jöerg Kempfert, MD, of Kerckhoff Clinic Bad ...

Cite this: Crossing Tricuspid-Valve Bioprosthesis With Pacer/ICD Lead Generally Safe - Medscape - Feb 21, 2012. References. Authors and Disclosures. Authors and Disclosures Journalist ...

“Most patients with a failing surgical bioprosthesis were successfully implanted with TAVR prosthesis in this multi-center feasibility study — improvements were sustained through 1 year,” Müller said.

Transcatheter bioprosthesis is an implantable medical device mostly used for patients suffering from severe symptomatic aortic stenosis of the aortic heart valve. In addition, transcatheter ...

In high-risk patients with degenerated mitral bioprosthesis, percutaneous antegrade transvenous mitral valve implantation appears to be a minimally invasive and highly effective strategy that has ...

PARIS – Healshape SAS is preparing a $6.8 million series A round to develop a 3D bioprinted breast implant obtained from the patients' own cells. Supported by Pulsalys SAS, Lyon Saint-Etienne’s ...

Evidence-based recommendations on transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis in adults. This involves inserting a new ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the first patient to receive its replacement tricuspid valved stent via transjugular access ...